Latest KFF Health News Stories
Readers Issue Rx for Clogged ERs and Outrageous Out-of-Pocket Costs
KFF Health News gives readers a chance to comment on a recent batch of stories.
The Chicken and Egg Problem of Fighting Another Flu Pandemic
The spread of an avian flu virus in cattle has again brought public health attention to the potential for a global pandemic. Fighting it would depend, for now, on 1940s technology that makes vaccines from hens’ eggs.
After Grilling an NIH Scientist Over Covid Emails, Congress Turns to Anthony Fauci
In a trove of emails brought to light through a congressional probe, a former close adviser to longtime National Institutes of Health official Anthony Fauci spoke of hiding messages from public disclosure.
KFF Health News' 'What the Health?': Waiting for SCOTUS
June is when the Supreme Court typically issues rulings in the major cases it hears during that year’s term. This year, those interested in health policy are awaiting decisions in two abortion-related cases and one that could reshuffle the way health policies (and all other federal policies) are made. In this special episode, KFF’s Laurie Sobel, associate director for women’s health policy, joins Julie Rovner for a review of the cases and a preview of how the court might rule.
An Obscure Drug Discount Program Stifles Use of Federal Lifeline by Rural Hospitals
A disconnect between two federal programs meant to help keep hospitals afloat discourages struggling rural facilities from accepting the aid.
Safety-Net Health Clinics Cut Services and Staff Amid Medicaid ‘Unwinding’
One of Montana’s largest safety-net health centers announced it will lay off nearly 10% of its workforce because of revenue losses it attributes to vast Medicaid disenrollments. Such cuts are happening elsewhere too.
Tennessee Gives This Hospital Monopoly an A Grade — Even When It Reports Failure
Ballad Health, a 20-hospital system in Tennessee and Virginia, benefits from the largest state-sanctioned hospital monopoly in the United States and is the only option for hospital care for a large swath of Appalachia.
Farmworkers Face High-Risk Exposures to Bird Flu, but Testing Isn’t Reaching Them
Federal officials are offering $75 to dairy workers who agree to be tested for bird flu. Advocates say the payments aren’t enough to protect workers from lost wages and health care costs if they test positive.
Psychoactive Drugs Are Having a Moment. The FDA Will Soon Weigh In.
Mounting evidence suggests psychoactive drugs including LSD, ketamine, mushrooms, and MDMA can be powerful treatments for severe depression and PTSD. But not everyone is convinced. And even if such drugs gain FDA approval, safety protocols could render them extremely expensive.
New Help for Dealing With Aggression in People With Dementia
A sedative shouldn’t be the first thing tried to help people with dementia who exhibit distressing behaviors. A new website is a comprehensive, free resource that offers guidance to caregivers.
FDA Urged To Relax Decades-Old Tissue Donation Restrictions for Gay and Bisexual Men
Federal regulations prevent gay and bisexual men from donating tissue, such as corneas, ligaments, and blood vessels. Similar restrictions have been relaxed or lifted for donated blood and organs in recent years.
The Case of the Armadillo: Is It Spreading Leprosy in Florida?
A single Central Florida county reported 13% of all U.S. leprosy cases in 2020. Researchers have teamed up to investigate whether armadillos are passing the bacteria that cause the disease to humans — which is especially concerning as the animals expand their range farther north.
KFF Health News' 'What the Health?': Anti-Abortion Hard-Liners Speak Up
While Republican candidates in many states downplay their opposition to abortion, the most vehement wing of the movement, which helped overturn Roe v. Wade — those who advocate prosecuting patients, outlawing contraception, and banning IVF — are increasingly outspoken. Meanwhile, some state legislatures continue to advance new restrictions, like a proposal moving in Louisiana to include abortion medications mifepristone and misoprostol on the list of the most dangerous drugs. Alice Miranda Ollstein of Politico, Rachel Roubein of The Washington Post, and Joanne Kenen of the Johns Hopkins schools of public health and nursing and Politico Magazine join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Shefali Luthra of The 19th about her new book on abortion in post-Roe America, “Undue Burden.”
Clues From Bird Flu’s Ground Zero on Dairy Farms in the Texas Panhandle
Dairy farmers and veterinarians in northern Texas furiously investigated a mysterious illness among cattle before the government got involved. Their observations are telling.
Los Angeles County Launches Ambitious Plan To Tackle Medical Debt. Hospitals Groan.
Los Angeles County, the nation’s most populous county, is spearheading a comprehensive plan to tackle a $2.9 billion medical debt crisis. Hospitals are still getting on board with the project, which is helmed by the public health department.
4 Ways Vaccine Skeptics Mislead You on Measles and More
Vaccine scare tactics haven’t shifted, but more parents are falling for them. Here’s what the rhetoric gets wrong and how it endangers children.
California Pays Meth Users To Get Sober
California’s Medicaid program is testing a novel approach for people addicted to methamphetamine, cocaine, and other stimulants. For every clean urine test, they can earn money — up to $599 a year.
He Fell Ill on a Cruise. Before He Boarded the Rescue Boat, They Handed Him the Bill.
A man from Michigan was evacuated from a cruise ship after having seizures. First, he drained his bank account to pay his medical bills.
Exclusive: Senator Urges Biden Administration To Thwart Fraudulent Obamacare Enrollments
With tens of thousands of Americans already affected by enrollment scams that leave some without doctors or treatments, Oregon Sen. Ron Wyden wants increased enforcement against rogue agents or other perpetrators and legislation to allow for criminal penalties.
High Price of Popular Diabetes Drugs Deprives Low-Income People of Effective Treatment
The makers of Ozempic and Mounjaro charge list prices of around $1,000 a month for the diabetes and obesity drugs, and insurers are reluctant to pick up the tab. Often, low-income patients have to resort to less effective treatments.
